GoAI
Get started
LEOCLAN Co.,Ltd. logo

LEOCLAN Co.,Ltd.

7681.T

JPXHealthcareMedical - Distribution

Open in GoAI

Latest quote

¥1,005

−¥38.00 · -3.64%

Aug 24, 1:12 PM JSTData delayed

7681.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

LEOCLAN Co.,Ltd. operates as a medical equipment trading firm, addressing diverse needs across medical care, welfare, and general health sectors. Its operations are structured into three main divisions: Medical Total Solutions Business, Remote Image Diagnosis Service Business, and School Lunch Business. The Medical Total Solutions Business segment delivers comprehensive services. This includes advisory support for selecting medical equipment, subsequent maintenance, and undertaking interior design, construction, and installation projects for medical facilities, preventive health centers, and nursing care institutions. Additionally, this segment is involved in the sale of medical devices and information systems. Through its Remote Image Diagnosis Service Business, the company facilitates the remote interpretation of imaging data from MRI, CT, and other scans by diagnostic radiology specialists, subsequently providing critical diagnostic information. Finally, the School Lunch Business segment offers a variety of meal services—including regular, therapeutic, and other specialized dietary options—to nursing care and welfare facilities. Established in 2001, LEOCLAN Co.,Ltd. is headquartered in Settsu, Japan.

Industry
Medical - Distribution
Sector
Healthcare
Headquarters
JP
CEO
Okitsugu Takeuchi
Listed since
Oct 2, 2019
Employees
155

Market position

Day range

Current ¥1,005

52-week range

Current ¥1,005

Open
¥1,013
Previous close
¥1,043
Volume
1.1K
0.38× average
Average volume
2.9K
Average daily volume
Market cap
5.95B JPY
Beta
0.12
Market reference 1
50-day average
¥939.34
+6.99% above average
200-day average
¥934.54
+7.54% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
1.88B JPY
EV / EBITDA
4.7×
Earnings yield
2.30%
Free cash flow yield
-1.75%

Profitability & efficiency

Return on equity
2.71%
Return on assets
1.40%
Return on invested capital
2.38%

Financial health

Current ratio
2.23×
Altman Z-score
2.7
Piotroski F-score
3 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends14%9%4%-1%Gross margin, FY2021: 10.37%Gross margin, FY2022: 10.27%Gross margin, FY2023: 10.58%Gross margin, FY2024: 13.22%Gross margin, FY2025: 12.76%Operating margin, FY2021: 2.19%Operating margin, FY2022: 2.19%Operating margin, FY2023: 1.65%Operating margin, FY2024: 0.90%Operating margin, FY2025: 1.34%Net margin, FY2021: 1.48%Net margin, FY2022: 1.47%Net margin, FY2023: 1.02%Net margin, FY2024: 0.69%Net margin, FY2025: 0.71%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 10.37%. Gross margin FY2022 10.27%. Gross margin FY2023 10.58%. Gross margin FY2024 13.22%. Gross margin FY2025 12.76%. Operating margin FY2021 2.19%. Operating margin FY2022 2.19%. Operating margin FY2023 1.65%. Operating margin FY2024 0.90%. Operating margin FY2025 1.34%. Net margin FY2021 1.48%. Net margin FY2022 1.47%. Net margin FY2023 1.02%. Net margin FY2024 0.69%. Net margin FY2025 0.71%.

Income trends

Revenue

21.49B JPY+8.51%

Operating income

288.29M JPY+61.86%

Net income

152.78M JPY+12.29%
Income trends across reported periods32.73B JPY20.88B JPY9.03B JPY−2.83B JPYRevenue, FY2021: 26.35B JPYRevenue, FY2022: 29.77B JPYRevenue, FY2023: 26.63B JPYRevenue, FY2024: 19.8B JPYRevenue, FY2025: 21.49B JPYOperating income, FY2021: 576.06M JPYOperating income, FY2022: 650.98M JPYOperating income, FY2023: 440.3M JPYOperating income, FY2024: 178.11M JPYOperating income, FY2025: 288.29M JPYNet income, FY2021: 390.98M JPYNet income, FY2022: 437.05M JPYNet income, FY2023: 271.31M JPYNet income, FY2024: 136.06M JPYNet income, FY2025: 152.78M JPYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 26.35B JPY. Revenue FY2022 29.77B JPY. Revenue FY2023 26.63B JPY. Revenue FY2024 19.8B JPY. Revenue FY2025 21.49B JPY. Operating income FY2021 576.06M JPY. Operating income FY2022 650.98M JPY. Operating income FY2023 440.3M JPY. Operating income FY2024 178.11M JPY. Operating income FY2025 288.29M JPY. Net income FY2021 390.98M JPY. Net income FY2022 437.05M JPY. Net income FY2023 271.31M JPY. Net income FY2024 136.06M JPY. Net income FY2025 152.78M JPY.
Metric (JPY)FY2025FY2024FY2023FY2022FY2021
Revenue21.49B JPY19.8B JPY26.63B JPY29.77B JPY26.35B JPY
Cost of goods sold18.75B JPY17.19B JPY23.81B JPY26.71B JPY23.61B JPY
Gross profit2.74B JPY2.62B JPY2.82B JPY3.06B JPY2.73B JPY
Selling, general, and administrative2.45B JPY2.44B JPY2.38B JPY2.4B JPY2.16B JPY
Operating expenses2.45B JPY2.44B JPY2.38B JPY2.4B JPY2.16B JPY
Interest income7.02M JPY431K JPY100K JPY750K JPY760K JPY
Interest expense2M JPY2M JPY17.84M JPY3.12M JPY3.54M JPY
Depreciation and amortization89.74M JPY99.49M JPY104.43M JPY96.28M JPY94.8M JPY
Operating income288.29M JPY178.11M JPY440.3M JPY650.98M JPY576.06M JPY
Net income152.78M JPY136.06M JPY271.31M JPY437.05M JPY390.98M JPY

Company facts updated Aug 24, 2026.

Earnings

Latest EPS result
7.56

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates95.2251.137.04-37.05Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Q4 2024, reported Nov 14, 2024: actual -9.18, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Feb 14, 2025: actual -27.78, estimate —, surprise —, Comparison unavailable. Q2 2025, reported May 15, 2025: actual 86.1, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 8, 2025: actual -4.53, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Nov 14, 2025: actual -27.93, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Feb 13, 2026: actual -13.46, estimate —, surprise —, Comparison unavailable. Q2 2026, reported May 15, 2026: actual 53.28, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Aug 7, 2026: actual 7.56, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates14.77B10.74B6.72B2.7BQ4 '24MissQ1 '25No estimateQ2 '25No estimateQ3 '25No estimateQ4 '25No estimateQ1 '26No estimateQ2 '26No estimateQ3 '26No estimate
Q4 2024, reported Nov 14, 2024: actual 4.09B JPY, estimate 6.8B JPY, surprise -39.86%, Miss. Q1 2025, reported Feb 14, 2025: actual 3.17B JPY, estimate —, surprise —, Comparison unavailable. Q2 2025, reported May 15, 2025: actual 9.77B JPY, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 8, 2025: actual 4.27B JPY, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Nov 14, 2025: actual 4.28B JPY, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Feb 13, 2026: actual 10.37B JPY, estimate —, surprise —, Comparison unavailable. Q2 2026, reported May 15, 2026: actual 13.91B JPY, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Aug 7, 2026: actual 11.9B JPY, estimate —, surprise —, Comparison unavailable.

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

¥17.00

2025 complete year-57.5% since 2021

Corporate action history

DividendUpcoming

Ex-dividend Sep 29, 2026

¥17.00

Annual

Record Sep 30, 2026 · Payment Sep 29, 2026

Dividend

Ex-dividend Sep 29, 2025

¥17.00

Annual

Record Sep 30, 2025 · Payment Dec 19, 2025

Dividend

Ex-dividend Sep 27, 2024

¥50.00

Annual

Record Sep 30, 2024 · Payment Dec 20, 2024

Dividend

Ex-dividend Sep 28, 2023

¥50.00

Annual

Dividend

Ex-dividend Sep 29, 2022

¥50.00

Annual

Dividend

Ex-dividend Sep 29, 2021

¥40.00

Annual

7681.T peers

Chugai Pharmaceutical Co., Ltd. logo

4519.T

Chugai Pharmaceutical Co., Ltd.

¥6,989

-0.31%

Takeda Pharmaceutical Company Limited logo

4502.T

Takeda Pharmaceutical Company Limited

¥5,817

+0.92%

HOYA Corporation logo

7741.T

HOYA Corporation

¥25,030

+0.54%

Otsuka Holdings Co., Ltd. logo

4578.T

Otsuka Holdings Co., Ltd.

¥12,280

+0.70%

Daiichi Sankyo Company, Limited logo

4568.T

Daiichi Sankyo Company, Limited

¥2,866.5

+1.16%

Astellas Pharma Inc. logo

4503.T

Astellas Pharma Inc.

¥2,405

+0.75%

Continue in GoAI

Research 7681.T

research.disclaimer